Actemra CAR-T-Related Indication Comes With Help From Novartis, Kite, US FDA

 
• By Sue Sutter
  
T-cells attacking cancer_1200x675
FDA approved Genentech's Actemra for treating CAR-T cell-related cytokine release syndrome
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews